IP Library Assignment 060811/0572
Patent Assignment
Reel/Frame 060811/0572

Assignment of Assignor's Interest

Recorded: 2022-08-15 Pages: 9
Assignors
SILK, JONATHAN DAVID
Executed: 2022-07-07
LAM, EMILY PUO SAN
Executed: 2022-07-21
SEVKO, ALEXANDRA
Executed: 2022-07-12
WILLIAMS, DENNIS ROBERT
Executed: 2022-08-03
BASU, SAMIK
Executed: 2022-07-07
Assignee
PALANTIR TECHNOLOGIES INC.
1555 BLAKE STREET, SUITE 250, DENVER, COLORADO, 80202
Covered Property (1)
Method of Treatment of Cancer or Tumour
Application: 17/812,304 →
Publication: US 2022/0370559
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 060811 Frame: 0572. Assignor(S) Hereby Confirms the Assignment. Oct 20, 2022
From: SILK, JONATHAN DAVID; LAM, EMILY PUO SAN; SEVKO, ALEXANDRA; WILLIAMS, DENNIS ROBERT
To: ADAPTIMMUNE LIMITED
Reel/Frame 062864/0755 →
Security Interest May 14, 2024
From: TCR2 THERAPEUTICS INC.; ADAPTIMMUNE LIMITED
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 067410/0105 →
Security Interest Jul 31, 2025
From: USWM, CT LLC
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 071900/0335 →
Release of Security Interest Jul 31, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: TCR2 THERAPEUTICS INC.; ADAPTIMMUNE LIMITED
Reel/Frame 072313/0252 →
Assignment of Assignor's Interest Aug 28, 2025
From: ADAPTIMMUNE LIMITED
To: USWM CT, LLC
Reel/Frame 072695/0013 →
Release of Security Interest Aug 28, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: TCR2 THERAPEUTICS INC.; ADAPTIMMUNE LIMITED
Reel/Frame 072700/0192 →